RxDoctor Payments Data

Lachelle Campbell, MD

Family Medicine · Mount Airy, MDNPI 1184870271

Payments from drug & device makers

$647in general payments, 2019–2025

Across 61 payments — averaging $10.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$299
  • Integra Lifesciences Corporation$125
  • Novo Nordisk$101
  • Exact Sciences$40
  • Boston Scientific$20
  • Boehringer Ingelheim$19
  • plus $43 from 3 others

What the payments were for

  • Food & beverage$62897%
  • Education$193%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$647 in reported general payments places this provider in the 60th percentile of 1,193 family medicine providers in Maryland.

See all family medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$38,344
Medicare patients
134
Services billed
397

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$48,446
EliquisApixaban33$42,662
JanuviaSitagliptin Phosphate29$41,344
MounjaroTirzepatide14$36,138
JardianceEmpagliflozin20$27,738
FarxigaDapagliflozin Propanediol12$17,176
Janumet XrSitagliptin Phos/Metformin Hcl17$15,853
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$8,722
Atorvastatin Calcium290$2,500
SynthroidLevothyroxine Sodium24$1,698
Nebivolol Hcl20$1,660
Albuterol Sulfate HfaAlbuterol Sulfate68$1,588
Pantoprazole Sodium117$1,586
Solifenacin Succinate11$1,580
Amlodipine Besylate292$1,546

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$101$48,44636 claims
Boehringer IngelheimJardiance$19$27,73820 claims
AbbVieSynthroid$299$1,69824 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,193 family medicine providers in Maryland.

Other family medicine in Mount Airy

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →